Immix Biopharma, Inc. (IMMX) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $11.04M | +13.9% |
| 2024 | $9.70M | +160.5% |
| 2023 | $3.72M | +112.9% |
| 2022 | $1.75M | +765.3% |
| 2021 | $202.0K | -96.2% |
| 2020 | $5.27M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $11.04M | +13.9% |
| 2024 | $9.70M | +160.5% |
| 2023 | $3.72M | +112.9% |
| 2022 | $1.75M | +765.3% |
| 2021 | $202.0K | -96.2% |
| 2020 | $5.27M | — |